ASML

1,179.6

+0.68%↑

SAP

148.54

-4.24%↓

IFX

-1.32%↓

NOKIA.FI

7.05

+2.92%↑

STMPA.FR

26.87

-0.63%↓

ASML

1,179.6

+0.68%↑

SAP

148.54

-4.24%↓

IFX

-1.32%↓

NOKIA.FI

7.05

+2.92%↑

STMPA.FR

26.87

-0.63%↓

ASML

1,179.6

+0.68%↑

SAP

148.54

-4.24%↓

IFX

-1.32%↓

NOKIA.FI

7.05

+2.92%↑

STMPA.FR

26.87

-0.63%↓

ASML

1,179.6

+0.68%↑

SAP

148.54

-4.24%↓

IFX

-1.32%↓

NOKIA.FI

7.05

+2.92%↑

STMPA.FR

26.87

-0.63%↓

ASML

1,179.6

+0.68%↑

SAP

148.54

-4.24%↓

IFX

-1.32%↓

NOKIA.FI

7.05

+2.92%↑

STMPA.FR

26.87

-0.63%↓

Home・Akcijų sąrašas・X-Fab Silicon Foundries SE

X-Fab Silicon Foundries SE

Atidarymo kaina

SektoriusTechnologijų sektorius

4.62 0.04

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.564

Max

4.734

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-15M 1.7M
Pardavimai	-4.8M 224M
P/E Sektoriaus vid.	23.84 77.27
Pelnas, tenkantis vienai akcijai	0.01
Pelno marža	0.78
Darbuotojai	4,300
EBITDA	-11M 47M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	+12.09% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-30

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-43M 623M
Ankstesnė atidarymo kaina	4.58
Ankstesnė uždarymo kaina	4.62

Naujienos nuotaikos

By Acuity

50%

163 / 376 reitingas Technology

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

4.88 / 4.958 Palaikymas ir pasipriešinimas

X-Fab Silicon Foundries SE Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Uždarbis

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

X-Fab Silicon Foundries SE Prognozė

Kainos tikslas

By TipRanks

12.09% į viršų

12 mėnesių prognozė

Vidutinis 5.1 EUR 12.09%

Aukščiausias 6 EUR

Žemiausias 4.3 EUR

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines X-Fab Silicon Foundries SE kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

Pirkti

Laikyti

Parduoti

Remiantis 4 analitikų, pateikusių X-Fab Silicon Foundries SE akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

4.88 / 4.958Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

Rinkos nuotaikos

By Acuity

163 / 376 reitingas Technologijų sektorius

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę X-Fab Silicon Foundries SE

X-FAB Silicon Foundries SE produces and sells analog/mixed-signal IC, micro-electro-mechanical systems, and silicon carbide products automotive, medical, industrial, and communication and consumer worldwide. It offers avalanche photodiodes and single-photon avalanche diodes; gas and flow sensors; image sensors; inertial sensors; photodiodes; pressure sensors; and temperature sensors. It also offers design support for electronic design automation platforms. X-FAB Silicon Foundries SE was founded in 1992 and is based in Tessenderlo, Belgium.